

Synthesis, characterization and preliminary pharmacological evaluation of new non-steroidal anti-inflammatory pyrazoline derivatives
Monther Faisal Mahdi (1)



(1) Department of Pharmaceutical Chemistry, College of Pharmacy, Al-Mustansiriyah University, Baghdad, 10001, Iraq
(2) Department of Pharmaceutical Chemistry, College of Pharmacy, Al-Mustansiriyah University, Baghdad, 10001, Iraq
(3) Department of Pharmaceutical Chemistry, College of Pharmacy, Al-Mustansiriyah University, Baghdad, 10001, Iraq
(*) Corresponding Author
Received: 13 Sep 2015 | Revised: 03 Oct 2015 | Accepted: 10 Oct 2015 | Published: 31 Dec 2015 | Issue Date: December 2015
Abstract
A series of six pyrazoline ring derivatives as a pharmacophore were incorporated to the naproxen; to increase its size were synthesized and preliminarly evaluated as anti-inflammatory agents with expected selectivity toward COX-2 enzyme. In vivo acute anti-inflammatory effects of the final compounds (5a-f) were evaluated in rats using egg-white induced edema model of inflammation. The tested compounds and the reference drug (naproxen) produced significant reduction of paw edema with respect to the effect of control group (propylene glycol 50%, v:v). However, compound 5d and 5e show comparable effect to naproxen at all experimental time while compounds 5a, 5b and 5c produced significantly lower inhibitory effect than naproxen at time 120-240 minutes. Furthermore, compound 5f exert significantly higher paw edema reduction than naproxen at 60-240 min. Also the antibacterial activities of the final compounds were evaluated by Well Diffusion Method. All tested compounds exert significant antibacterial activity against tested Gram positive and Gram negative bacteria in comparison to dimethyl sulfoxide as control group. In comparison the antibacterial results among the tested compound 5e may regard the best one and compound 5c the lower one.
Announcements
Our editors have decided to support scientists to publish their manuscripts in European Journal of Chemistry without any financial constraints.
1- The article processing fee will not be charged from the articles containing the single-crystal structure characterization or a DFT study between September 15, 2023 and October 31, 2023 (Voucher code: FALL2023).
2. A 50% discount will be applied to the article processing fee for submissions made between September 15, 2023 and October 31, 2023 by authors who have at least one publication in the European Journal of Chemistry (Voucher code: AUTHOR-3-2023).
3. Young writers will not be charged for the article processing fee between September 15, 2023 and October 31, 2023 (Voucher code: YOUNG2023).
Editor-in-Chief
European Journal of Chemistry
Keywords
Full Text:
PDF

DOI: 10.5155/eurjchem.6.4.461-467.1321
Links for Article
| | | | | | |
| | | | | | |
| | | |
Related Articles
Article Metrics


Funding information
Department of Pharmaceutical Chemistry, College of Pharmacy, Al-Mustansiriyah University, Baghdad, 10001, Iraq
Citations
[1]. Yaseen A. M. M. Elshaier, Ashraf A. Aly, Mohamed Abdel-Aziz, Hazem M. Fathy, Alan B. Brown, Stefan Bräse, Mohamed Ramadan
Synthesis and Identification of New N,N-Disubstituted Thiourea, and Thiazolidinone Scaffolds Based on Quinolone Moiety as Urease Inhibitor
Molecules 27(20), 7126, 2022
DOI: 10.3390/molecules27207126

[2]. Ayad M. R. Raauf, Rafah F. Al-Smaism, Khalida A. Thejeel, Hala Ayad M. Rasheed
Synthesis, characterization and antimicrobial study via new heterocyclic derivatives of trimethoprim
Natural Product Research 33(9), 1277, 2019
DOI: 10.1080/14786419.2018.1470516

[3]. Maysoon Mohammed Almahdi, Ahmed Elsadig Mohammed Saeed, Nadia Hanafy Metwally
Synthesis and antimicrobial activity of some new pyrazoline derivatives bearing sulfanilamido moiety
European Journal of Chemistry 10(1), 30, 2019
DOI: 10.5155/eurjchem.10.1.30-36.1791

[4]. Shahlaa Zuhair Abdul-Majeed, Monther Faisal Mahdi, Suhad Faisal Hatem Al-Mugdadi
Design, Molecular Docking Studies, Synthesis and Characterization of some New 4,5-dihydro-1H- Pyrazole-1-yl acetate Derivatives as Cyclooxygenase Inhibitors
Research Journal of Pharmacy and Technology , 3382, 2022
DOI: 10.52711/0974-360X.2022.00566

[5]. Nadia Hanafy Metwally, Mohamed Ahmed Badawy, Doha Samir Okpy
Green synthesis of some new thiopyrano[2,3-d][1,3]thiazoles using lemon juice and their antibacterial activity
Synthetic Communications 48(19), 2496, 2018
DOI: 10.1080/00397911.2018.1495234

References
[1]. Laine, L. Rev. Gastroenterol. Disord. 2004, 4(4), S33-S41.
[2]. Scheiman, J. M. Rev. Gastroenterol. Disord. 2005, 5(2), S39-S49.
[3]. Antonietta, M.; Bernardo, A.; Greco, A.; Minghetti, L. Pharma. 2010, 3, 1949-1964.
[4]. Mizushima, T. Pharma. 2010, 3, 1614-1636.
[5]. Wittine, K.; Benci, K.; Rajic, Z.; Zorc, B.; Kralj, M.; Marjanovic, M.; Pavelic, K.; DeClercq, E.; Andrei, G.; Snoeck, R.; Balzarini, J.; Mintas, M. Eur. J. Med. Chem. 2009, 44(1), 143-151.
http://dx.doi.org/10.1016/j.ejmech.2008.03.037
[6]. Singh, G.; Triadafilopoulos, G. J. Rheumatol. 1999, 56, 18-24.
[7]. Chiroli, V.; Benedini, F. Eur. J. Med. Chem. 2003, 38, 441-446.
http://dx.doi.org/10.1016/S0223-5234(03)00055-2
[8]. Byrno, C. Am. J. Gastroenterol. 2011, 1694-1695.
[9]. John, L.; Linda, V. Curr. Opin. Invest. D 2008, 9(11), 1151-1156.
[10]. Mahdi, M. F; Mohammed, M. H; Jassim, A. A. Molecules 2012, 17, 1751-1763.
http://dx.doi.org/10.3390/molecules17021751
[11]. Seibert, K.; Zhang, Y.; Leahy, K.; Hauser, S.; Masferrer, J.; Isakson, P. Adv. Exp. Med. Biol. 1997, 400, 167-170.
http://dx.doi.org/10.1007/978-1-4615-5325-0_24
[12]. Paloucek, F. P.; Rynn, K. O. In Clinical Toxicology; Ford, M. D., Ed.; WB Saunders, 2001.
[13]. Katzung, B. G. (Ed.), Basic and clinical pharmacology, 9th edition, McGraw-Hill, 2004.
[14]. Claus, S.; Boeglin, E.; Brash, A. Biochem. J. 2005, 385, 57-64.
http://dx.doi.org/10.1042/BJ20041115
[15]. Zidar, N.; Odar, K.; Glavac, D.; Jerse, M. J. Cell. Mole. Med. 2009, 13, 3753-3763.
http://dx.doi.org/10.1111/j.1582-4934.2008.00430.x
[16]. Curtis-Prior, P. The Eicosanoid, 1st edition, John Wiley and Sons, 2004.
http://dx.doi.org/10.1002/0470020628
[17]. Solomon, D. H.; Furst, D. E. S. Afr. Pharm. J. 2009, 8, 18-22.
[18]. Pratico, D.; Dogne, J. M. Circulation 2005, 112, 1073-1079.
http://dx.doi.org/10.1161/CIRCULATIONAHA.104.524231
[19]. Hilario, M.; Terreri, M.; Len, C. J. De Pediatria. 2006, 82(5), 206-212.
http://dx.doi.org/10.1590/S0021-75572006000700011
[20]. Zarraga, I. G. E.; Schwarz, E. R. J. Am. Coll. Cardiol. 2007, 49(1), 1-14.
http://dx.doi.org/10.1016/j.jacc.2006.10.003
[21]. Hawkey, C. J. Lancet 1999, 353, 307 -314.
http://dx.doi.org/10.1016/S0140-6736(98)12154-2
[22]. Bombardier, C.; Laine, L.; Reicin, A.; Shapiro, D.; Burgos-Vargas, R.; Davis, B. New Engl. J. Med. 2000, 343, 1520-1528.
http://dx.doi.org/10.1056/NEJM200011233432103
[23]. Raymond, M. P. J. Am. Osteo. Assos. 2004, 104(11), 19-24.
[24]. Silverman, D. G.; Halaszynski, T.; Sinatra, R.; Luther, M.; Rinder, C. S. Can. J. Anaesth. 2003, 50, 1004-1008.
http://dx.doi.org/10.1007/BF03018363
[25]. Verma, A.; Saraf, S. K. Eur. Med. Chem. 2008, 43(5), 897-905.
http://dx.doi.org/10.1016/j.ejmech.2007.07.017
[26]. Beena, V.; Saleh, N.; Akhr-Eldin, O.; Salma, M. Mol. Biomol. Spectrosc. 2015, 136, 661-671.
http://dx.doi.org/10.1016/j.saa.2014.09.080
[27]. Indorkar, D.; Chourasia, O. P.; Limaye, S. Int. J. Curr. Microbiol. 2015, 4(2), 670-678.
[28]. Caroline, C.; Catherine, M. Eur. J. Med. Chem. 2003, 38, 645-659.
http://dx.doi.org/10.1016/S0223-5234(03)00115-6
[29]. Lee, B.; Kwak, J. H.; Huang, S. W.; Jang, J. Y.; Lim, S.; Kwak, Y. S,; Lee, K.; Kim, H. S.; Han, S. B.; Hong, J. T.; Lee, H.; Song, S.; Seo, S. Y.; Jung, J. K. Bioorg. Med. Chem. 2012, 20(9), 2860-2868.
http://dx.doi.org/10.1016/j.bmc.2012.03.028
[30]. Grosser, T. Thromb. Haemost. 2006, 96, 393-400.
[31]. Asiri, A.; Marwani, H.; Alamry, K.; Al-Amoudi, M.; Khan, S.; El-Daly, S. Int. J. Electrochem. Sci. 2014, 9, 799-809.
[32]. Bakht, M.; Ansari, M. Int. J. Biol. Pharm. All Sci. 2014, 3(5), 705-717.
[33]. Kantharaju; Vommina, V. Indian J. Chem. 2006, 45, 1942-1944.
[34]. Mahdi. M. F.; Raauf, A. M.; Kadhim, F. A. J. Nat. Sci. Res. 2015, 5(6), 21-28.
[35]. Salem, B.; Mahdi, F.; Mohammed, H. Iraqi J. Pharm. Sci. 2009, 18(2), 39.
[36]. Lichtenberger, M.; Dial, E.; Romero, J.; Moore, J. E. Inflammopharmacology 2008, 16, 1-5.
http://dx.doi.org/10.1007/s10787-006-1604-7
[37]. Neli, L.; Yogendra, K.; Berington, M. J. Med. Plan. Res. 2011, 5(5), 859-861.
[38]. Naser, N. H; Mahdi, M. F; Omer, T. N. Iraqi J. Pharma. Sci. 2011, 20(1), 25-32.
[39]. Verma, S.; Anurekh, J.; Jain, A.; Gupta, V. Int. J. Pharm. Biosci. 2010, 1(2), 1-7.
[40]. Meshram, G. G.; Kumar, A.; Rizvi, W.; Tripathi, C. D.; Khan, R. A. J. Trad. Comp. Med. 2015, 1-4.
How to cite
The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item
DOI Link: https://doi.org/10.5155/eurjchem.6.4.461-467.1321

















European Journal of Chemistry 2015, 6(4), 461-467 | doi: https://doi.org/10.5155/eurjchem.6.4.461-467.1321 | Get rights and content
Refbacks
- There are currently no refbacks.
Copyright (c)
© Copyright 2010 - 2023 • Atlanta Publishing House LLC • All Right Reserved.
The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.
Copyright 2010-2023 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.